Evaluation of an Oat Fiber Supplement on Health
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Oat Fiber, Placebo.
- Who it may be relevant to
- Registry conditions: Supplementation Efficacy in Health Adults on Plasticizer Removal. Basic parameters: 18 years — 40 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of the study is to determine whether short-term use of an oat fiber supplement reduces exposure to your urine levels of dietary chemicals like bisphenol A (BPA). This study will also examine whether supplementation with NeutraOat oat fiber influences blood glucose levels using continuous glucose monitoring.
Detailed description
The purpose of this study is to evaluate whether short-term supplementation of oat fiber reduces exposure to plasticizers following a controlled dietary exposure and whether any resulting changes influence glycemic responses.
Interventions
- Dietary supplement Oat Fiber
4 grams of supplementation by capsule per day for two days - Dietary supplement Placebo
4 grams of supplementation (placebo) by capsule per day for two days
Primary outcome measures
- Urine Plasticizer Concentration [Time frame: Urine samples will be take over the course of three weeks.]
Secondary outcome measures (1)
- Blood Glucose Levels [Time frame: Blood glucose levels will be monitored over the course of 3 weeks.]
Eligibility criteria
Inclusion criteria
- Participants will be healthy
- Weight-stable for the previous 6 months
- Free of any metabolic or chronic disease
- Non-smoking (to include vaping and other nicotine or THC containing products)
- Participate in less than 250 minutes of moderate to vigorous physical activity per week
Exclusion criteria
- Any chronic or metabolic disease, including type 1 or type 2 diabetes
- Gastrointestinal (GI) diseases/disorders
- Neurologic or psychiatric conditions
- Nicotine or THC consumption
- Unsafe dieting practices
- Special diets (e.g. vegan, low-carbohydrate, gluten-free, dairy-free, etc.)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple blind
- Primary purpose
- Other
Study locations
United States · 1 center
- California Polytechnic State University — San Luis Obispo
Identifiers
NCT: NCT07714135 · 2026-CP